Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
THE LANCET. GASTROENTEROLOGY & HEPATOLOGY
Rivista
Codice:
E241391
ISSN:
2468-1253
Dati Generali
Dati Generali
Pubblicazioni (27)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A DEF perspective on the METAPAC study
Articolo
A global scientific strategy to cure hepatitis B
Articolo
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial
Articolo
Bridging gaps in surgical care for neuroendocrine tumours: CUTNETs begins
Articolo
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey
Articolo
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
Articolo
Diffusion-weighted MRI in inflammatory bowel disease
Articolo
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
Articolo
Early-onset colorectal cancer: trends and challenges
Articolo
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial
Articolo
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
Articolo
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
Articolo
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
Articolo
Improving the quality of surveillance colonoscopy in inflammatory bowel disease
Articolo
Infliximab biosimilar CT-P13 for inflammatory bowel disease
Articolo
Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trial
Articolo
Launch of the PANC-PALS Consortium
Articolo
Lessons and open questions in borderline resectable pancreatic cancer
Articolo
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
Articolo
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study
Articolo
Per-oral endoscopic myotomy versus laparoscopic Heller's myotomy plus Dor fundoplication in patients with idiopathic achalasia: 5-year follow-up of a multicentre, randomised, open-label, non-inferiority trial
Articolo
Protecting patients with IBD during the COVID-19 pandemic
Articolo
Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial
Articolo
Scientific and medical evidence informing expansion of hepatitis B treatment guidelines
Articolo
Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial
Articolo
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Articolo
Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
